文献速递肿瘤 PET/CT放射性药物与辐射防护

68Ga-FAPI-46 PET/CT 中的胆囊生理性摄取

Physiological Gallbladder Accumulation on 68 Ga-FAPI-46 PET/CT.
PubMed 文献 · Clin Nucl Med · 2024-10-10

放射性标记成纤维细胞激活蛋白抑制剂(FAPI)是肿瘤检测与治疗的新方法,靶向肿瘤相关成纤维细胞产生的成纤维细胞激活蛋白。本文展示一例68Ga-FAPI在胆囊的生理性摄取,强调准确判读以避免误诊并确保有效患者管理。

要点

  • 68Ga-FAPI-46 PET/CT 可见胆囊生理性摄取,判读时需注意识别。
  • FAPI 靶向肿瘤相关成纤维细胞产生的成纤维细胞激活蛋白。
  • 准确判读胆囊生理性摄取有助于避免误诊并确保有效患者管理。

核心结论

  • 68Ga-FAPI在胆囊的生理性积聚需准确判读,以防误诊并确保有效患者管理。

研究设计与样本

  • 本文为图像展示,呈现68Ga-FAPI在胆囊的生理性积聚。

主要发现

  • 图像显示68Ga-FAPI在胆囊的生理性积聚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiolabeled fibroblast activation protein inhibitors (FAPIs) are a novel approach in cancer detection and treatment. Targeting fibroblast activation protein, extensively produced by cancer-associated fibroblasts, FAPI plays a key role in tumor development. Its advanced imaging capabilities offer clearer results in solid tumors compared with traditional methods, drawing significant interest in oncology. Additionally, FAPI's activity in conditions requiring tissue remodeling, such as atherosclerosis and arthritis, highlights its broader potential. This interesting image shows the physiological accumulation of 68 Ga-FAPI in the gallbladder, emphasizing the importance of accurate interpretation to prevent misdiagnoses and ensure effective patient management.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Şahin ÖF, Alçın G, Ergül N, et al. Physiological Gallbladder Accumulation on 68 Ga-FAPI-46 PET/CT. Clin Nucl Med. 2024. PMID: 39466623. doi:10.1097/RLU.0000000000005480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。